Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 4
2003 3
2004 6
2005 6
2006 6
2007 7
2008 10
2009 8
2010 12
2011 6
2012 13
2013 25
2014 16
2015 22
2016 27
2017 20
2018 27
2019 32
2020 39
2021 38
2022 42
2023 54
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

394 results

Results by year

Filters applied: . Clear all
Page 1
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial.
Lu YS, Im SA, Colleoni M, Franke F, Bardia A, Cardoso F, Harbeck N, Hurvitz S, Chow L, Sohn J, Lee KS, Campos-Gomez S, Villanueva Vazquez R, Jung KH, Babu KG, Wheatley-Price P, De Laurentiis M, Im YH, Kuemmel S, El-Saghir N, O'Regan R, Gasch C, Solovieff N, Wang C, Wang Y, Chakravartty A, Ji Y, Tripathy D. Lu YS, et al. Among authors: ji y. Clin Cancer Res. 2022 Mar 1;28(5):851-859. doi: 10.1158/1078-0432.CCR-21-3032. Clin Cancer Res. 2022. PMID: 34965945 Free PMC article. Clinical Trial.
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
Slamon D, Lipatov O, Nowecki Z, McAndrew N, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, Fasching PA, Crown J, Bardia A, Chia S, Im SA, Ruiz-Borrego M, Loi S, Xu B, Hurvitz S, Barrios C, Untch M, Moroose R, Visco F, Afenjar K, Fresco R, Severin I, Ji Y, Ghaznawi F, Li Z, Zarate JP, Chakravartty A, Taran T, Hortobagyi G. Slamon D, et al. Among authors: ji y. N Engl J Med. 2024 Mar 21;390(12):1080-1091. doi: 10.1056/NEJMoa2305488. N Engl J Med. 2024. PMID: 38507751 Clinical Trial.
Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis.
Han H, Wang Y, Curto J, Gurrapu S, Laudato S, Rumandla A, Chakraborty G, Wang X, Chen H, Jiang Y, Kumar D, Caggiano EG, Capogiri M, Zhang B, Ji Y, Maity SN, Hu M, Bai S, Aparicio AM, Efstathiou E, Logothetis CJ, Navin N, Navone NM, Chen Y, Giancotti FG. Han H, et al. Among authors: ji y. Cell Rep. 2022 Apr 5;39(1):110595. doi: 10.1016/j.celrep.2022.110595. Cell Rep. 2022. PMID: 35385726 Free PMC article.
Magnetic-responsive Covalent Adaptable Networks.
Liang H, Wei Y, Ji Y. Liang H, et al. Among authors: ji y. Chem Asian J. 2023 Mar 1;18(5):e202201177. doi: 10.1002/asia.202201177. Epub 2023 Jan 26. Chem Asian J. 2023. PMID: 36645376 Review.
FBXO22 degrades nuclear PTEN to promote tumorigenesis.
Ge MK, Zhang N, Xia L, Zhang C, Dong SS, Li ZM, Ji Y, Zheng MH, Sun J, Chen GQ, Shen SM. Ge MK, et al. Among authors: ji y. Nat Commun. 2020 Apr 6;11(1):1720. doi: 10.1038/s41467-020-15578-1. Nat Commun. 2020. PMID: 32249768 Free PMC article.
Emerging Roles of Lipophagy in Cancer Metastasis.
Yin H, Shan Y, Xia T, Ji Y, Yuan L, You Y, You B. Yin H, et al. Among authors: ji y. Cancers (Basel). 2022 Sep 19;14(18):4526. doi: 10.3390/cancers14184526. Cancers (Basel). 2022. PMID: 36139685 Free PMC article. Review.
Reprocessable Thermoset Soft Actuators.
Yang Y, Terentjev EM, Zhang Y, Chen Q, Zhao Y, Wei Y, Ji Y. Yang Y, et al. Among authors: ji y. Angew Chem Int Ed Engl. 2019 Nov 25;58(48):17474-17479. doi: 10.1002/anie.201911612. Epub 2019 Oct 22. Angew Chem Int Ed Engl. 2019. PMID: 31529672 Review.
394 results